Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Abbvie Inc N.ABBV


Primary Symbol: ABBV

Healthcare Biotechnology
AbbVie Inc. is a diversified research-based biopharmaceutical company engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers a comprehensive product portfolio across Immunology, Oncology, Neuroscience, Eye Care, Aesthetics, and Other Specialties. Immunology includes Rheumatology, Dermatology, and Gastroenterology. Oncology includes Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Diffuse large B-cell lymphoma, and others. Neuroscience includes Parkinson's disease, Migraine, Movement Disorders, Psychiatric Disorders, and Alzheimer’s disease. Eye Care includes Chronic Dry Eye Disease, Glaucoma, Age-Related Retinal Diseases, and Refractive Disorders. Aesthetics includes Botox Cosmetic, The Juvederm Collection of Fillers, and others. It offers NX-13 for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). It also offers CEL383 for the treatment of inflammatory bowel disease.


NYSE:ABBV - Post by User

Abbvie Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(229)
•••
Post by whytestockson Oct 30, 2024 5:00pm
41 Views
Post# 36289507

Canadian Companies Moving the Markets, Evening edition <br>W

Canadian Companies Moving the Markets, Evening edition <br>W
BREAKING NEWS: $ABBV Canadian Companies Moving the Markets, Evening edition <br>Wed, Oct 30, 2024 as of 4:00 pm ETA look at the top 10 most actives in Canada Talon Metals Corp. (TLO) rose 0.0% to $0.085 on volume of 119,347,427 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 3.0% to $2.23 on volume of 11,024,661 shares Tvi Pacific Inc. (TVI) fell 50.0% to $0.005 on volume of 10,545,800 s...ABBV - Canadian Companies Moving the Markets, Evening edition <br>Wed, Oct 30, 2024 as of 4:00 pm ET

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities